Duration of Dual Antiplatelet Therapy in Patients with CKD and Drug-Eluting Stents: A Meta-Analysis.

Thomas A MavrakanasYiannis S ChatzizisisKarim GarianiDean J KereiakesGiuseppe GargiuloGérard HelftMartine GilardFausto FeresRicardo A CostaMarie-Claude MoriceJean-Louis GeorgesMarco ValgimigliDeepak L BhattLaura MauriDavid M Charytan

Published in: Clinical journal of the American Society of Nephrology : CJASN (2019)

Short DAPT does not appear to be inferior to longer DAPT in patients with CKD and drug-eluting stents. Because of imprecision in estimates (few events and wide confidence intervals), no definite conclusions can be drawn with respect to stent thrombosis.

Keyphrases

antiplatelet therapy
acute coronary syndrome
percutaneous coronary intervention
chronic kidney disease
pulmonary embolism
coronary artery disease
adverse drug
drug induced
emergency department
electronic health record